60 years of Cimicifuga racemosa medicinal products: Clinical research milestones, current study findings and current development

Cimicifuga racemosa (CR) extracts are important worldwide as therapy for menopausal symptoms. The first medicinal product from CR has been available since 1956 (Germany, Remifemin® [Schaper & Brümmer, Salzgitter, Germany], isopropanolic extract iCR). This review describes how CR developed, via c...

Descripción completa

Detalles Bibliográficos
Autor principal: Henneicke-von Zepelin, Hans-Heinrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2017
Materias:
Main Topic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409920/
https://www.ncbi.nlm.nih.gov/pubmed/28155126
http://dx.doi.org/10.1007/s10354-016-0537-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409920/
https://www.ncbi.nlm.nih.gov/pubmed/28155126
http://dx.doi.org/10.1007/s10354-016-0537-z

Ejemplares similares